Experience of short-term hydroxychloroquine and azithromycin in COVID-19 patients and effect on QTc trend - 25/07/20
Doi : 10.1016/j.jinf.2020.05.058
Chee Peng Hor a, b, c, ⁎ 
, Narwani Hussin d , Saravanaa Nalliah e , Way Ti Ooi e , Xing Yi Tang e , Sara Zachariah e , Gurpreet pal Singh Jugindar Singh e , Rosilawati Abdul Rani d , Kunaraj Perumal e , Wee Kooi Cheah d, e, ⁎
, Narwani Hussin d , Saravanaa Nalliah e , Way Ti Ooi e , Xing Yi Tang e , Sara Zachariah e , Gurpreet pal Singh Jugindar Singh e , Rosilawati Abdul Rani d , Kunaraj Perumal e , Wee Kooi Cheah d, e, ⁎ a Institute for Clinical Research, National Institutes of Health, Blok D, No 1, Jalan Setia Murni U13/ 52, Seksyen U13, Setia Alam, 40170 Shah Alam, Selangor, Malaysia
b Clinical Research Centre, Seberang Jaya Hospital, Jalan Tun Hussein Onn, Seberang Jaya, 13700, Permatang Pauh, Pulau Pinang
c Department of Medicine, Kepala Batas Hospital, Jalan Bertam 2, 13200, Kepala Batas, Penang, Malaysia
d Clinical Research Centre, Taiping Hospital, Jalan Taming Sari, 34000, Taiping, Perak, Malaysia
e Department of Medicine, Taiping Hospital, Jalan Taming Sari, 34000, Taiping, Perak, Malaysia
⁎Corresponding author: Cheah Wee Kooi, Department of Medicine, Taiping, Hospital, Jalan Taming Sari, 34000 Taiping, Perak, Malaysia, Tel: (605)8083333, Fax: (605)8074517.Department of MedicineTaiping, HospitalJalan Taming SariTaipingPerak34000Malaysia⁎⁎Hor Chee Peng, Institute for Clinical Research, National Institutes of Health, Blok D, No 1, Jalan Setia Murni U13/ 52, Seksyen U13, Setia Alam, 40170 Shah Alam, Selangor, Malaysia, Tel: 603-3362 7700, Fax: 603-3362 7701.Institute for Clinical ResearchNational Institutes of HealthBlok D, No 1, Jalan Setia Murni U13/ 52, Seksyen U13, Setia AlamShah AlamSelangor40170Malaysia
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Keywords : COVID-19, Hydroxychloroquine, Azithromycin, QT prolongation, Risk assessment
Le texte complet de cet article est disponible en PDF.
© 2020
The British Infection Association. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 81 - N° 2
P. e117-e119 - août 2020 Retour au numéro
Article précédent
- Fatality rate of COVID-19 in patients with malignancies: a sytematic review and meta-analysis
- Zeinab Mohseni Afshar, Maliheh Dayani, Mehdi Naderi, Farnia Ghanbarveisi, Samira Shiri, Fatemeh Rajati
- Qualitative serology in patients recovered from SARS CoV 2 infection
- Paulo Bettencourt, Catarina Fernandes, Ana Gil, Antonio Almeida, Margarida Alvelos
Bienvenue sur EM-consulte, la référence des professionnels de santé.